SuperworthFennec Pharmaceuticals shares outstanding FENC
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 36.4M
- On a year earlier
- +31.7%
- more shares
Fennec Pharmaceuticals had 36.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 31.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 31.1M | +15% |
| FY2024 | 27.1M | +1% |
| FY2023 | 26.7M | −0% |
| FY2022 | 26.8M | +3% |
| FY2021 | 26M | +0% |
| FY2020 | 25.9M | +30% |
| FY2019 | 19.9M | +0% |
| FY2018 | 19.8M | +21% |
| FY2017 | 16.4M | +20% |
| FY2016 | 13.6M | +25% |
| FY2015 | 10.9M | +10% |
| FY2014 | 9.9M | −40% |
| FY2013 | 16.6M | +98% |
| FY2012 | 8.4M | +1% |
| FY2011 | 8.3M | −41% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 36.4M | +32% | |
| Q1 FY26 | 35.5M | +29% | |
| Q4 FY25 | 31.1M | +15% | |
| Q3 FY25 | 27.9M | +2% | |
| Q2 FY25 | 27.7M | +1% | |
| Q1 FY25 | 27.6M | −11% | |
| Q4 FY24 | 27.1M | +1% | |
| Q3 FY24 | 27.4M | +3% | |
| Q2 FY24 | 27.3M | +3% | |
| Q1 FY24 | 31.1M | +17% | |
| Q4 FY23 | 26.7M | −0% | |
| Q3 FY23 | 26.6M | +2% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Fennec Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.